Bayer AG Sponsored ADR
XDUS
Closed
Jul 22, 2026
Day's Range
11.6052 wk Range
6.00Key Statistics
Symbol
BAYA
Name
Bayer AG Sponsored ADR
Currency
EUR
Exchange
XDUS
High
11.70000
Low
11.60000
Open
‪11.70‬
Last
‪11.60‬
Market Cap
0
Pe Ratio
‪-12.60‬
Volume
0
Average Volume
10
Dividend Yield
‪0.24%‬
Change
-0.10
Percent Change
-0.85
Timestamp
2026-07-22
Close
11.60000
Today Range Start
‪11.60‬
Today Range End
‪11.70‬
52 Week Range Start
‪6.00‬
52 Week Range End
‪13.10‬
Type
Stocks
Country
Germany
Compliance - BAYA - Bayer AG Sponsored ADR
Compliance
Status
COMPLIANT
Report Date
2025-02-18
Business Screen
COMPLIANT
Financial Screen
COMPLIANT
Compliant Revenue
‪99.00%‬
Non Compliant Revenue
‪0.00%‬
Questionable Revenue
‪1.00%‬
Securities To Market Cap Ratio
‪1.00%‬
Debt To Market Cap Ratio
‪3.00%‬
Historical Data - BAYA - Bayer AG Sponsored ADR
Historical Data
Dividend - BAYA - Bayer AG Sponsored ADR
Dividend
2026-04-28
0.0269
Earnings - BAYA - Bayer AG Sponsored ADR
Earnings
Balance Sheet - BAYA - Bayer AG Sponsored ADR
Balance Sheet
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
 Assets | 104.54B | 110.85B | 116.25B | 124.87B | 120.24B | 116.80B |
| Liabilities | 78.47B | 78.80B | 83.18B | 85.95B | 87.07B | 86.12B |
| Shareholders Equity | 26.06B | 32.04B | 33.07B | 38.92B | 33.16B | 30.67B |
Cash Flow - BAYA - Bayer AG Sponsored ADR
Cash Flow
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Operating Activities | - | - | - | - | - | - |
| Investing Activities | - | - | - | - | - | - |
| Financing Activities | - | - | - | - | - | - |
| End Cash Position | 6.67B | 6.19B | 5.90B | 5.17B | 4.56B | 4.19B |
| Income Tax Paid | - | - | - | - | - | - |
| Interest Paid | - | - | - | - | - | - |
| Free Cash Flow | 3.44B | 4.59B | 2.36B | 4.14B | 2.47B | 2.48B |
Income Statement - BAYA - Bayer AG Sponsored ADR
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 45.57B | 46.60B | 47.63B | 50.73B | 44.08B | 41.40B |
| Cost of Goods | 18.79B | 21.27B | 19.74B | 19.87B | 16.81B | 19.13B |
| Gross Profit | 26.77B | 25.33B | 27.88B | 30.86B | 27.26B | 22.26B |
| Operating Expense | - | - | - | - | - | - |
| Operating Income | 6.13B | 3.32B | 8.03B | 7.33B | 6.90B | -714M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -3.12B | -2.33B | -1.62B | 4.67B | 2.04B | -17.25B |
| Income Tax | 466M | 212M | 1.32B | 504M | 1.02B | -1.68B |
| Net Income | -3.59B | -2.54B | -2.94B | 4.16B | 1.02B | -10.48B |
| EPS Basic | -0.92 | -0.65 | -0.7475 | 1.055 | 0.255 | -2.67 |
| EPS Diluted | -0.92 | -0.65 | -0.7475 | 1.055 | 0.255 | -2.67 |
| Basic Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Diluted Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Ebit | -864M | 24M | 426M | 6.52B | 3.39B | -15.65B |
| Ebitda | 9.11B | 8.97B | 11.19B | 12.76B | 10.03B | 10.32B |
| Net Income Continuous Operations | -3.59B | -2.54B | -2.94B | 4.16B | 1.02B | -15.56B |
| Minority Interests | -25M | -6M | 1M | -16M | -22M | -8M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Profile - BAYA - Bayer AG Sponsored ADR
Profile
Mic Code
XDUS
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
88.50K
Bayer AG Sponsored ADR represents an American Depositary Receipt for Bayer AG, a multinational corporation headquartered in Leverkusen, Germany. As an ADR, it facilitates U.S. investors' access to foreign stock markets, enabling them to invest in Bayer AG's shares while trading on the U.S. stock exchanges. Bayer is prominently known for its operations in three major divisions: Pharmaceuticals, Consumer Health, and Crop Science. It is a significant player in the pharmaceutical industry, recognized for innovations in cardiovascular health, oncology, and women's health. Additionally, Bayer's Consumer Health segment caters to over-the-counter products, while its Crop Science division is a leading entity in agricultural solutions, focusing on high-quality seeds, chemical, and biological crop protection. The company's influence spans various sectors, reflecting a strong presence in life sciences and agriculture. Bayer AG Sponsored ADRs play an essential role in making the company's diverse portfolio accessible to a broader range of investors, offering them a way to engage with international markets through a familiar financial instrument.
Profile Details
Type
American Depositary Receipt
Ceo
Mr. William N. Anderson
Address
Kaiser-Wilhelm-Allee 1
City
Leverkusen
Zip
51368
Country
Germany
Phone
49 214 30 1
